TNFRSF9 and myelodysplastic syndrome: While the ability for IgGs to permeate the immunological synapse is not well-understood, such interactions could additionally occur in the presence of proteolytically shed 4-1BB as seen in patients with hematological malignancies such as myelodysplastic syndrome and acute myeloid leukemia56,57.